Department Dermatology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.
Railway Clinical Hospital, 700506 Iasi, Romania.
Medicina (Kaunas). 2022 Nov 3;58(11):1589. doi: 10.3390/medicina58111589.
Sentinel lymph node biopsy (SLNB) is a surgical procedure that has been used in patients with cutaneous melanoma for nearly 30 years. It is used for both staging and regional disease control with minimum morbidity, as proven by numerous worldwide prospective studies. It has been incorporated in the recommendations of national and professional guidelines. In this article, we provide a summary of the general information on SLNB in the clinical guidelines for the management of cutaneous malignant melanoma (American Association of Dermatology, European Society of Medical Oncology, National Comprehensive Cancer Network, and Cancer Council Australia) and review the most relevant literature to provide an update on the existing recommendations for SLNB.
前哨淋巴结活检 (SLNB) 是一种在皮肤黑色素瘤患者中应用近 30 年的手术。它通过多项全球前瞻性研究证实，具有最小的发病率，可用于分期和区域疾病控制。它已被纳入国家和专业指南的建议中。在本文中，我们总结了皮肤恶性黑色素瘤管理临床指南（美国皮肤病学会、欧洲肿瘤内科学会、美国国家综合癌症网络和澳大利亚癌症委员会）中关于 SLNB 的一般信息，并回顾了最相关的文献，以提供 SLNB 现有建议的最新信息。
